The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The global Human Microbiome market was valued at US$ 384.9 million in 2023 and is anticipated to reach US$ 1544.9 million by 2030, witnessing a CAGR of 21.7% during the forecast period 2024-2030.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome.
Report Scope
The Human Microbiome market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Vedanta
- Seres Therapeutics
- Second Genome
- Rebiotix
- ActoGeniX
- Enterome BioScience
- AvidBiotics
- 4D Pharma Research Ltd
- Enterologics
- Metabogen
- Metabiomics
- Ritter Pharmaceuticals
- Osel
- Symberix
- Miomics
- Symbiotix Biotherapies
- MicroBiome Therapeutics LLC
Segment by Type
- Gastrointestinal Tract Human Micobiome
- Urogenital Tract Human Micobiome
- Others
Segment by Application
- Treatment
- Diagnosis
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Gastrointestinal Tract Human Micobiome
1.2.3 Urogenital Tract Human Micobiome
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Market Perspective (2019-2030)
2.2 Human Microbiome Growth Trends by Region
2.2.1 Global Human Microbiome Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Market Dynamics
2.3.1 Human Microbiome Industry Trends
2.3.2 Human Microbiome Market Drivers
2.3.3 Human Microbiome Market Challenges
2.3.4 Human Microbiome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Players by Revenue
3.1.1 Global Top Human Microbiome Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Revenue
3.4 Global Human Microbiome Market Concentration Ratio
3.4.1 Global Human Microbiome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Revenue in 2023
3.5 Human Microbiome Key Players Head office and Area Served
3.6 Key Players Human Microbiome Product Solution and Service
3.7 Date of Enter into Human Microbiome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Breakdown Data by Type
4.1 Global Human Microbiome Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Breakdown Data by Application
5.1 Global Human Microbiome Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Market Size (2019-2030)
6.2 North America Human Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Market Size by Country (2019-2024)
6.4 North America Human Microbiome Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Market Size (2019-2030)
7.2 Europe Human Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Market Size (2019-2030)
9.2 Latin America Human Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Vedanta
11.1.1 Vedanta Company Detail
11.1.2 Vedanta Business Overview
11.1.3 Vedanta Human Microbiome Introduction
11.1.4 Vedanta Revenue in Human Microbiome Business (2019-2024)
11.1.5 Vedanta Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Detail
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Business (2019-2024)
11.2.5 Seres Therapeutics Recent Development
11.3 Second Genome
11.3.1 Second Genome Company Detail
11.3.2 Second Genome Business Overview
11.3.3 Second Genome Human Microbiome Introduction
11.3.4 Second Genome Revenue in Human Microbiome Business (2019-2024)
11.3.5 Second Genome Recent Development
11.4 Rebiotix
11.4.1 Rebiotix Company Detail
11.4.2 Rebiotix Business Overview
11.4.3 Rebiotix Human Microbiome Introduction
11.4.4 Rebiotix Revenue in Human Microbiome Business (2019-2024)
11.4.5 Rebiotix Recent Development
11.5 ActoGeniX
11.5.1 ActoGeniX Company Detail
11.5.2 ActoGeniX Business Overview
11.5.3 ActoGeniX Human Microbiome Introduction
11.5.4 ActoGeniX Revenue in Human Microbiome Business (2019-2024)
11.5.5 ActoGeniX Recent Development
11.6 Enterome BioScience
11.6.1 Enterome BioScience Company Detail
11.6.2 Enterome BioScience Business Overview
11.6.3 Enterome BioScience Human Microbiome Introduction
11.6.4 Enterome BioScience Revenue in Human Microbiome Business (2019-2024)
11.6.5 Enterome BioScience Recent Development
11.7 AvidBiotics
11.7.1 AvidBiotics Company Detail
11.7.2 AvidBiotics Business Overview
11.7.3 AvidBiotics Human Microbiome Introduction
11.7.4 AvidBiotics Revenue in Human Microbiome Business (2019-2024)
11.7.5 AvidBiotics Recent Development
11.8 4D Pharma Research Ltd
11.8.1 4D Pharma Research Ltd Company Detail
11.8.2 4D Pharma Research Ltd Business Overview
11.8.3 4D Pharma Research Ltd Human Microbiome Introduction
11.8.4 4D Pharma Research Ltd Revenue in Human Microbiome Business (2019-2024)
11.8.5 4D Pharma Research Ltd Recent Development
11.9 Enterologics
11.9.1 Enterologics Company Detail
11.9.2 Enterologics Business Overview
11.9.3 Enterologics Human Microbiome Introduction
11.9.4 Enterologics Revenue in Human Microbiome Business (2019-2024)
11.9.5 Enterologics Recent Development
11.10 Metabogen
11.10.1 Metabogen Company Detail
11.10.2 Metabogen Business Overview
11.10.3 Metabogen Human Microbiome Introduction
11.10.4 Metabogen Revenue in Human Microbiome Business (2019-2024)
11.10.5 Metabogen Recent Development
11.11 Metabiomics
11.11.1 Metabiomics Company Detail
11.11.2 Metabiomics Business Overview
11.11.3 Metabiomics Human Microbiome Introduction
11.11.4 Metabiomics Revenue in Human Microbiome Business (2019-2024)
11.11.5 Metabiomics Recent Development
11.12 Ritter Pharmaceuticals
11.12.1 Ritter Pharmaceuticals Company Detail
11.12.2 Ritter Pharmaceuticals Business Overview
11.12.3 Ritter Pharmaceuticals Human Microbiome Introduction
11.12.4 Ritter Pharmaceuticals Revenue in Human Microbiome Business (2019-2024)
11.12.5 Ritter Pharmaceuticals Recent Development
11.13 Osel
11.13.1 Osel Company Detail
11.13.2 Osel Business Overview
11.13.3 Osel Human Microbiome Introduction
11.13.4 Osel Revenue in Human Microbiome Business (2019-2024)
11.13.5 Osel Recent Development
11.14 Symberix
11.14.1 Symberix Company Detail
11.14.2 Symberix Business Overview
11.14.3 Symberix Human Microbiome Introduction
11.14.4 Symberix Revenue in Human Microbiome Business (2019-2024)
11.14.5 Symberix Recent Development
11.15 Miomics
11.15.1 Miomics Company Detail
11.15.2 Miomics Business Overview
11.15.3 Miomics Human Microbiome Introduction
11.15.4 Miomics Revenue in Human Microbiome Business (2019-2024)
11.15.5 Miomics Recent Development
11.16 Symbiotix Biotherapies
11.16.1 Symbiotix Biotherapies Company Detail
11.16.2 Symbiotix Biotherapies Business Overview
11.16.3 Symbiotix Biotherapies Human Microbiome Introduction
11.16.4 Symbiotix Biotherapies Revenue in Human Microbiome Business (2019-2024)
11.16.5 Symbiotix Biotherapies Recent Development
11.17 MicroBiome Therapeutics LLC
11.17.1 MicroBiome Therapeutics LLC Company Detail
11.17.2 MicroBiome Therapeutics LLC Business Overview
11.17.3 MicroBiome Therapeutics LLC Human Microbiome Introduction
11.17.4 MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2019-2024)
11.17.5 MicroBiome Therapeutics LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Human Microbiome Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Gastrointestinal Tract Human Micobiome
Table 3. Key Players of Urogenital Tract Human Micobiome
Table 4. Key Players of Others
Table 5. Global Human Microbiome Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Human Microbiome Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Human Microbiome Market Share by Region (2019-2024)
Table 9. Global Human Microbiome Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Human Microbiome Market Share by Region (2025-2030)
Table 11. Human Microbiome Market Trends
Table 12. Human Microbiome Market Drivers
Table 13. Human Microbiome Market Challenges
Table 14. Human Microbiome Market Restraints
Table 15. Global Human Microbiome Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Human Microbiome Market Share by Players (2019-2024)
Table 17. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2023)
Table 18. Ranking of Global Top Human Microbiome Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Human Microbiome Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Product Solution and Service
Table 22. Date of Enter into Human Microbiome Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Revenue Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Human Microbiome Revenue Market Share by Type (2025-2030)
Table 28. Global Human Microbiome Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Human Microbiome Revenue Market Share by Application (2019-2024)
Table 30. Global Human Microbiome Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Human Microbiome Revenue Market Share by Application (2025-2030)
Table 32. North America Human Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Human Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Human Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Human Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Human Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Human Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Human Microbiome Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Human Microbiome Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Human Microbiome Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Human Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Human Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Human Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Human Microbiome Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Human Microbiome Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Human Microbiome Market Size by Country (2025-2030) & (US$ Million)
Table 47. Vedanta Company Detail
Table 48. Vedanta Business Overview
Table 49. Vedanta Human Microbiome Product
Table 50. Vedanta Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 51. Vedanta Recent Development
Table 52. Seres Therapeutics Company Detail
Table 53. Seres Therapeutics Business Overview
Table 54. Seres Therapeutics Human Microbiome Product
Table 55. Seres Therapeutics Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 56. Seres Therapeutics Recent Development
Table 57. Second Genome Company Detail
Table 58. Second Genome Business Overview
Table 59. Second Genome Human Microbiome Product
Table 60. Second Genome Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 61. Second Genome Recent Development
Table 62. Rebiotix Company Detail
Table 63. Rebiotix Business Overview
Table 64. Rebiotix Human Microbiome Product
Table 65. Rebiotix Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 66. Rebiotix Recent Development
Table 67. ActoGeniX Company Detail
Table 68. ActoGeniX Business Overview
Table 69. ActoGeniX Human Microbiome Product
Table 70. ActoGeniX Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 71. ActoGeniX Recent Development
Table 72. Enterome BioScience Company Detail
Table 73. Enterome BioScience Business Overview
Table 74. Enterome BioScience Human Microbiome Product
Table 75. Enterome BioScience Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 76. Enterome BioScience Recent Development
Table 77. AvidBiotics Company Detail
Table 78. AvidBiotics Business Overview
Table 79. AvidBiotics Human Microbiome Product
Table 80. AvidBiotics Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 81. AvidBiotics Recent Development
Table 82. 4D Pharma Research Ltd Company Detail
Table 83. 4D Pharma Research Ltd Business Overview
Table 84. 4D Pharma Research Ltd Human Microbiome Product
Table 85. 4D Pharma Research Ltd Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 86. 4D Pharma Research Ltd Recent Development
Table 87. Enterologics Company Detail
Table 88. Enterologics Business Overview
Table 89. Enterologics Human Microbiome Product
Table 90. Enterologics Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 91. Enterologics Recent Development
Table 92. Metabogen Company Detail
Table 93. Metabogen Business Overview
Table 94. Metabogen Human Microbiome Product
Table 95. Metabogen Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 96. Metabogen Recent Development
Table 97. Metabiomics Company Detail
Table 98. Metabiomics Business Overview
Table 99. Metabiomics Human Microbiome Product
Table 100. Metabiomics Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 101. Metabiomics Recent Development
Table 102. Ritter Pharmaceuticals Company Detail
Table 103. Ritter Pharmaceuticals Business Overview
Table 104. Ritter Pharmaceuticals Human Microbiome Product
Table 105. Ritter Pharmaceuticals Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 106. Ritter Pharmaceuticals Recent Development
Table 107. Osel Company Detail
Table 108. Osel Business Overview
Table 109. Osel Human Microbiome Product
Table 110. Osel Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 111. Osel Recent Development
Table 112. Symberix Company Detail
Table 113. Symberix Business Overview
Table 114. Symberix Human Microbiome Product
Table 115. Symberix Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 116. Symberix Recent Development
Table 117. Miomics Company Detail
Table 118. Miomics Business Overview
Table 119. Miomics Human Microbiome Product
Table 120. Miomics Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 121. Miomics Recent Development
Table 122. Symbiotix Biotherapies Company Detail
Table 123. Symbiotix Biotherapies Business Overview
Table 124. Symbiotix Biotherapies Human Microbiome Product
Table 125. Symbiotix Biotherapies Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 126. Symbiotix Biotherapies Recent Development
Table 127. MicroBiome Therapeutics LLC Company Detail
Table 128. MicroBiome Therapeutics LLC Business Overview
Table 129. MicroBiome Therapeutics LLC Human Microbiome Product
Table 130. MicroBiome Therapeutics LLC Revenue in Human Microbiome Business (2019-2024) & (US$ Million)
Table 131. MicroBiome Therapeutics LLC Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Market Share by Type: 2023 VS 2030
Figure 3. Gastrointestinal Tract Human Micobiome Features
Figure 4. Urogenital Tract Human Micobiome Features
Figure 5. Others Features
Figure 6. Global Human Microbiome Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Microbiome Market Share by Application: 2023 VS 2030
Figure 8. Treatment Case Studies
Figure 9. Diagnosis Case Studies
Figure 10. Human Microbiome Report Years Considered
Figure 11. Global Human Microbiome Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Human Microbiome Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Human Microbiome Market Share by Region: 2023 VS 2030
Figure 14. Global Human Microbiome Market Share by Players in 2023
Figure 15. Global Top Human Microbiome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Human Microbiome Revenue in 2023
Figure 17. North America Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Human Microbiome Market Share by Country (2019-2030)
Figure 19. United States Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Human Microbiome Market Share by Country (2019-2030)
Figure 23. Germany Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Human Microbiome Market Share by Region (2019-2030)
Figure 31. China Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Human Microbiome Market Share by Country (2019-2030)
Figure 39. Mexico Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Human Microbiome Market Share by Country (2019-2030)
Figure 43. Turkey Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Human Microbiome Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Vedanta Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 46. Seres Therapeutics Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 47. Second Genome Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 48. Rebiotix Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 49. ActoGeniX Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 50. Enterome BioScience Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 51. AvidBiotics Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 52. 4D Pharma Research Ltd Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 53. Enterologics Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 54. Metabogen Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 55. Metabiomics Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 56. Ritter Pharmaceuticals Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 57. Osel Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 58. Symberix Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 59. Miomics Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 60. Symbiotix Biotherapies Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 61. MicroBiome Therapeutics LLC Revenue Growth Rate in Human Microbiome Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
